Research Highlights from ASCO 2026
View Fight CRC’s June 2026 Clinical Trials Webinar for a recap of key colorectal cancer research highlights from the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.
In this session, Dr. Christopher Cann (Fox Chase Cancer Center) and Fight CRC Research Advocate Allison Rosen share their perspectives on the most impactful colorectal cancer research presented at ASCO 2026. Learn about promising clinical trial results, advances in precision medicine, and emerging research that could shape future treatment options and patient care.
Fight CRC independently develops and curates all content.
Editor’s Note: The CHALLENGE trial (ASCO 2025) showed that a structured, supervised exercise program (including support from a personal trainer) significantly improved disease-free survival compared to a health education-only control group. The takeaway is that the type and structure of exercise matters. Please speak with your care team about what’s right for you.
Regarding ctDNA testing in the US: Natera offers financial assistance programs that may reduce or waive costs for uninsured patients, though eligibility applies. Contact Natera’s patient services team directly to explore your options.